Dan Tong-Castillo

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Therapeutic Effects of Lurbinectedin in PARP Inhibitor-Resistant High-Grade Serous Ovarian Cancer Using Patient-Derived Cell Lines and Organoid Models.

Therapeutic Effects of Lurbinectedin in PARP Inhibitor-Resistant High-Grade Serous Ovarian Cancer Using Patient-Derived Cell Lines and Organoid Models.

Journal: International journal of molecular sciences

Published: August 07, 2025

AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.

AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.

Journal: British journal of cancer

Published: December 04, 2022

SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer.

SLCO4A1 expression is associated with activated inflammatory pathways in high-grade serous ovarian cancer.

Journal: Frontiers in pharmacology

Published: May 17, 2022

Decision Theory versus Conventional Statistics for Personalized Therapy of Breast Cancer.

Decision Theory versus Conventional Statistics for Personalized Therapy of Breast Cancer.

Journal: Journal of personalized medicine

Published: February 17, 2022

Vitamin D Analogs Regulate the Vitamin D System and Cell Viability in Ovarian Cancer Cells.

Vitamin D Analogs Regulate the Vitamin D System and Cell Viability in Ovarian Cancer Cells.

Journal: International journal of molecular sciences

Published: September 23, 2021

Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients.

Tumor Growth Rate Estimates Are Independently Predictive of Therapy Response and Survival in Recurrent High-Grade Serous Ovarian Cancer Patients.

Journal: Cancers

Published: February 01, 2021

Decision theory for precision therapy of breast cancer.

Decision theory for precision therapy of breast cancer.

Journal: Scientific reports

Published: June 26, 2020

Microarray Normalization Revisited for Reproducible Breast Cancer Biomarkers.

Microarray Normalization Revisited for Reproducible Breast Cancer Biomarkers.

Journal: BioMed research international

Published: December 04, 2019

Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer.

Interrelations of Sphingolipid and Lysophosphatidate Signaling with Immune System in Ovarian Cancer.

Journal: Computational and structural biotechnology journal

Published: November 20, 2018

Co-expressed genes enhance precision of receptor status identification in breast cancer patients.

Co-expressed genes enhance precision of receptor status identification in breast cancer patients.

Journal: Breast cancer research and treatment

Published: July 03, 2018

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).

Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).

Journal: British journal of cancer

Published: February 18, 2018

Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.

Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 15, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026